Rolandic Epilepsy Genomewide Association International Study (REGAIN)
Research type
Research Study
Full title
Rolandic Epilepsy Genomewide Association International Study (REGAIN)
IRAS ID
229844
Contact name
Deb Pal
Contact email
Sponsor organisation
King's College London
Duration of Study in the UK
2 years, 11 months, 3 days
Research summary
Epilepsy is a common neurological disorder affecting 1% of the population. There are over 30 types of epilepsy, some common, some rare. Most epilepsies arise in childhood and have a genetic cause. Approximately 25% of child patients have “Rolandic Epilepsy” or RE, also known as Benign Epilepsy with Centrotemporal Spikes (BECTS). RE has a complex genetic basis, probably made up of combinations of susceptibility variants in different genes. The goal of this study is to find the genetic basis for susceptibility to seizures and associated comorbidities for RE using genomewide association approaches.
REC name
London - London Bridge Research Ethics Committee
REC reference
18/LO/0207
Date of REC Opinion
12 Apr 2018
REC opinion
Further Information Favourable Opinion